SLC9A1 and leukemia: Further support for the approach of co-administering compounds in combination with lactate transport inhibitors, is the result of a study that showed that co-administration of MCT inhibitor with cariporide (a powerful NHE1 blocker), had an additive effect on leukemia cell growth inhibition [217].